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Abstract
Objective: The majority of patients counseled for prenatal 
open spina bifida repair (SBR) do not undergo fetal surgery. 
The aim of this study was to analyze the reasons for this phe-
nomenon. Materials and Methods: The data of the first 160 
patients seeking counseling or referred to the Zurich Center 
for Fetal Diagnosis and Therapy for prenatal SBR between 
December 2010 and March 2017 were retrospectively ana-
lyzed. Results: A total of 104 (65%) patients did not undergo 
prenatal SBR. Of this subgroup, 52% met the exclusion crite-
ria, 35% decided to terminate pregnancy, 4% chose to con-
tinue pregnancy without fetal intervention, and 3% sought 
care in other European centers. In 6%, data about the ensu-
ing course of pregnancy were not recorded. The main exclu-
sion criteria were delayed presentation (30%), absence of 
hindbrain herniation (28%), and concomitant spinal anoma-
lies (17%). Conclusion: The high percentage of patients not 
qualifying for prenatal SBR underscores the necessity of a 
standard evaluation of every single patient at a qualified re-
ferral center. To allow a higher proportion of women carry-
ing a fetus with open spina bifida to be timely and correctly 
informed about a potential fetal intervention, much more 
effort is mandatory to spawn correct, objective, and under-
standable information among all groups of people poten-
tially exposed to this topic. © 2018 S. Karger AG, Basel
Introduction
The MOMS Trial has shown that prenatal open spina 
bifida repair (SBR) including myelomeningocele and its 
noncystic variant, myeloschisis, is beneficial for selected 
patients [1]. In comparison to postnatal repair, the overall 
percentage of prenatal repair patients requiring a ventric-
uloperitoneal shunt is reduced to half (from 80 to 42%, 
p < 0.001), and the percentage of patients walking inde-
pendently is doubled (from 21 to 42%, p = 0.01). In addi-
tion, prenatal SBR leads to a reversal of hindbrain hernia-
tion in the majority of cases. Hindbrain herniation is a 
characteristic feature of Chiari II malformation and is 
practically always present in patients with open spina bi-
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fida (SB). In up to 33% of patients operated postnatally it 
causes cranial nerve, cerebellar, and medullary respira-
tory center dysfunction [2–4]. Reversal of hindbrain her-
niation after fetal SBR can largely prevent these poten-
tially life-threatening dysfunctions. Further, persistent 
improvement of neurofunctional outcomes has been re-
ported in a nonrandomized study that evaluated patients 
at a median age of 10 years after prenatal SBR [5].
However, despite these benefits, not all patients prof-
it from prenatal SBR. Some will still require a ventriculo-
peritoneal shunt or have no improvement in motor func-
tion, and deficits in executive functions and adaptive 
skills are reported to be higher in patients undergoing 
prenatal SBR compared to a normal population [5]. In 
addition, the effect of prenatal repair on urological out-
come, a crucial problem in patients with SB, is still un-
clear. A substudy of the MOMS Trial [6] demonstrated 
no significant reduction in the need for clean intermit-
tent catheterization after prenatal SBR, but showed de-
creased bladder wall trabeculation and less open bladder 
necks. The significance of these findings in a long-term 
perspective is not known. However, some studies, in-
cluding an own investigation, reported that prenatal re-
pair may have a positive impact on lower urinary tract 
function [7, 8].
Seen in a critical light, the results of prenatal SBR are 
not perfect and beside that, a certain shadow falls over the 
possible benefits by the inherent risks of the procedure. 
Prenatal repair is associated with prematurity and with 
possible complications due to the uterine scar, including 
risk of uterine dehiscence and rupture [1]. Moreover, al-
though studies have shown that prenatal SBR does not 
affect fertility, every subsequent pregnancy requires a ce-
sarean section [9]. Despite these critical considerations, 
the undisputable benefits that can be achieved for a se-
lected group of patients with prenatal SBR clearly out-
weigh the risks. Thus, prenatal repair by open fetal sur-
gery is offered as a novel treatment option.
In light of the above problems associated with prenatal 
SBR and bearing in mind the relatively small incidence of 
SB, it is absolutely crucial that prenatal SBR be confined 
to a few high-volume and highly qualified fetal surgery 
centers worldwide where a multidisciplinary team of ex-
perts and an adequate infrastructure are readily available 
[10]. These places typically serve as referral centers for 
large areas not necessarily confined to geographic bound-
aries. For example, our Zurich Center for Fetal Diagnosis 
and Therapy (www.swissfetus.ch) is one of the very few 
established centers in Europe offering comprehensive 
prenatal evaluation and counseling, prenatal SBR, and a 
standardized long-term follow-up (up to 18 years of age) 
of all patients in a specific Pediatric Spina Bifida Center. 
Our fetal surgery program has been in existence for 7 
years and gets requests and referrals not only from Swit-
zerland, but also from most European as well as from 
many extra-European countries.
While we have accumulated a relatively large experi-
ence of over 80 operated cases so far, we are, in parallel, 
observing that a majority of patients referred to our center 
do not undergo prenatal SBR. Therefore, the aim of this 
study was to analyze the reasons for that phenomenon. 
We hypothesize that such an analysis will cast light on a 
number of crucial medical, social, and maybe also logisti-
cal issues. We further postulate that a detailed under-
standing of factors determining or influencing decision 
making is a precious resource for improvements, adapta-
tions, and modifications regarding our system of care.
Materials and Methods
The data of the first 160 patients referred to our center between 
December 2010 and March 2017 were analyzed retrospectively. 
Included were “classical” referrals, i.e., patients formally referred 
after evaluation and preliminary counseling by an outside special-
ist, but also self-referrals, i.e., patients that contacted us directly 
after having heard from us or found information on our program 
on the internet. Hence, we evaluated all charts of patients who had 
both on-site standard evaluation (according to MOMS [1]) and 
prenatal counseling at our center, but also notes of phone calls and 
e-mails as well as imaging material from patients not traveling to 
Zurich because they were excluded a priori (e.g., twin pregnancy) 
or because the information given by phone/e-mail was sufficient 
for them to choose another option (e.g., termination of pregnan-
cy). Data were recorded and analyzed with Microsoft Excel 2013.
Results
Of the 160 patients included in the study, 111 (69%) 
were evaluated on-site. The remaining 49 (31%) were pa-
tients whose basic information obtained by phone or 
e-mail revealed that they had exclusion criteria or who, 
after receiving preliminary basic information by phone or 
e-mail, decided to terminate pregnancy without an ap-
pointment at our center.
Of the 160 patients, 104 (65%) did not undergo prena-
tal SBR. In this subgroup, 54 cases (52%) met the exclu-
sion criteria (Fig. 1), and 37 patients (35%) decided to ter-
minate pregnancy. Four (4%) chose to continue pregnan-
cy without fetal intervention, and 3 (3%) sought care in 
other European centers, among them a center offering 
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fetoscopic repair. The records of 6 patients (6%) stated 
only that prenatal repair was declined (no details given).
The main exclusion criteria were presentation after 26 
weeks of gestation (n = 16, 30%) and absence of hindbrain 
herniation (n = 15, 28%). Spinal anomalies were identi-
fied in 9 patients (17%), including 5 patients (9%) with 
caudal regression syndrome (CRS). Two of the 5 patients 
with CRS had CRS alone and 3 had additional spinal de-
formities. Four other patients (7%) were excluded for ky-
phosis (> 30°). A lesion level below S1 was encountered in 
5 patients (9%), all of whom also demonstrated absent 
hindbrain herniation. Two patients (4%) were excluded 
because of cervical location of the lesion. Severe brain 
anomalies (7%), heart defects (4%), genetic anomalies 
(4%), and a hydrops fetalis were other fetal pathologies 
found in excluded patients. One fetus had ventriculomeg-
aly, aqueductal stenosis, agenesis of the corpus callosum, 
caudal displacement of the cerebellum, and talipes, but no 
SB was found on exams, whereupon the patient was ex-
cluded.
On the maternal side, exclusions were made due to 
twin pregnancies (n = 4, 7%), history of prematurity in 
former pregnancies (n = 3, 6%), body mass index > 35 
(n = 2, 4%), and psychological issues (n = 2, 4%). HIV 
positivity (n = 1, 2%) and a hydatid mole (n = 1, 2%) were 
other reasons. One woman did not qualify for fetal sur-
gery due to a complicated index pregnancy with a history 
of failed abortion and placenta accreta/increta (n = 1, 2%). 
In 16 cases (30%), more than one exclusion criterion was 
present (two criteria in 12 patients and three criteria in 4 
patients). These data are summarized in Table 1.
Discussion
This is the first analysis explicitly looking in detail at 
the large group of women carrying a fetus with SB who do 
not undergo prenatal repair. A number of findings are 
worth commenting.
In our study, 65% of all patients did not have fetal sur-
gery, and only a minority of 35% finally underwent pre-
natal repair. Similarly, the Children’s Hospital of Phila-
delphia reported in their post-MOMS experience that 
only 17.2% of referred patients underwent fetal surgery 
[11]. These data highlight the fact that, apparently, a rig-
orous scrutiny takes place and that, consequently, only a 
meticulously selected group of patients with SB is ulti-
mately eligible for and treated by fetal surgery.
Further, we speculate that a considerable number of 
patients never get in touch with a center that offers fetal 
Fetal
repair
56 (35%)
No fetal
repair
104 (65%)
Patient’s
wish
50 (48%)
Exclusion
criteria
54 (52%)
Table 1. Fetal and maternal exclusion criteria found in the 54 pa-
tients not qualifying for fetal spina bifida repair
Exclusion criteria n %
Fetal
Absence of hindbrain herniation 15 27.8
Spinal anomalies 9 16.7
CRS with additional spine deformity 3
CRS alone 2
Kyphosis >30° 4
Lesion below S1 and above T1 7 12.9
Below S11 5
Above T1 2
Additional severe brain anomalies 4 7.4
Fetal cardiac anomalies 2 3.7
Genetic mutations 2 3.7
No spina bifida 1 1.9
Hydrops fetalis 1 1.9
Maternal
Presentation after 26 weeks 16 29.6
Multiple pregnancy 4 7.4
Prematurity in prior pregnancy 3 5.6
Body mass index >35 2 3.7
Psychological issues 2 3.7
PA/PI, history of failed RU-496 abortion 1 1.9
HIV positivity 1 1.9
Hydatid mole 1 1.9
Combination of 2 criteria (fetal and/or maternal) 12 22.2
Combination of 3 criteria 4 7.4
The sum of the percentages exceeds 100% due to presence of 
more than one exclusion criterion in some of the patients. CRS, 
caudal regression syndrome; PA, placenta accreta; PI, placenta 
increta. 1 All with concomitant missing hindbrain herniation.
Fig. 1. Distribution of patients who were referred to us or contact-
ed our center for possible prenatal spina bifida repair.
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surgery. Therefore, the “true” percentage of all patients 
with SB undergoing prenatal repair is even lower.
Another important conclusion resulting from this 
study is that the exclusion criteria are met quite frequent-
ly. In fact, they were the most common reason why re-
ferred patients did not undergo fetal SBR. The fact that 
exclusion criteria are frequently present underscores the 
paramount importance of a vigilant and highly profes-
sional workup by an experienced expert team in order not 
to miss possible exclusion criteria as this may have delete-
rious consequences for the mother and the fetus. The total 
percentage of exclusion criteria found in our study (52%) 
is comparable to that reported in the MOMS Trial (56%) 
[1] and also in the post-MOMS experience (59%) [11].
Of note, most centers offering prenatal SBR have basi-
cally adopted and still vigorously impose the core exclu-
sion criteria set forth by the MOMS Trial. Yet, this field 
is slowly changing, and disparate practices already exist 
among centers [12].
In our cohort, the most frequent exclusion criterion was 
presentation too late in gestation. Why is this, theoreti-
cally speaking, easily avoidable problem so dominant? 
From nonsystematic inquiries we guess that the option of 
fetal surgery is still not common knowledge among gen-
eral practitioners and non-hospital-based specialists in ob-
stetrics and gynecology. Furthermore, in larger hospitals 
and certainly in fetal-maternal medicine centers, the op-
tion is mostly well known, but there is still considerable 
skepticism with regard to this innovative therapy. As a 
consequence, patients may not be informed timely and 
correctly about a potential intervention before birth. In our 
experience, some patients develop an astounding self-ini-
tiative, sometimes after considerable trials and tribulations 
with doctors and insurance companies. They then contact 
our center directly, yet, at times too late. Thus, much more 
effort is mandatory to spawn correct, objective, under-
standable, and nondirective information among all groups 
of people potentially coming into contact with this topic. 
Obviously, this includes not only physicians and paramed-
ical professionals, but also the public and the media.
In the context of timely referral, economic aspects may 
play an important role. Fetal surgery is expensive, and this 
is especially true for Switzerland. While patients from 
Switzerland get full coverage by mandatory health insur-
ance, the financial aspects are sometimes complex for pa-
tients from abroad. Under EU law, European citizens have 
the right to obtain planned medical treatment in any EU 
country (including Switzerland) under certain circum-
stances and to be reimbursed by their national health in-
surance. However, prior authorization from the health in-
surer is needed. In most cases, this represents a serious 
challenge because of time constraints (intervention must 
often be done before coverage is ascertained). Conse-
quently, we are often forced to operate without guaran-
teed cost coverage, and sometimes our “FetOpera” Fund 
must shoulder deficits. Thanks to this subsidize option, we 
did not have to turn down patients for financial reasons.
The second most frequent exclusion criterion was 
missing hindbrain herniation. Definitely, this seems to be 
a nondebatable exclusion criterion, as it indicates that the 
SB under examination in all likelihood belongs to the cat-
egory of closed dysraphism (meningocele, myelocysto-
cele, lipomyelomeningocele), i.e., that the lesion is cov-
ered by skin, meningeal, or connective tissue so that the 
spinal cord tissue is not directly exposed to amniotic fluid. 
Obviously, fetal intervention in such a situation would be 
futile. An important caveat is that sonography and MRI of 
the back lesion do not always allow for recognition of the 
dysraphism type beyond doubt, and here missing hind-
brain herniation provides a very useful indirect, yet high-
ly indicative, information. Fetal MRI allows to best visual-
ize the presence or absence of hindbrain herniation and is 
thus mandatory for prenatal diagnostic workup [13, 14].
Spinal anomalies, including CRS as well as other severe 
malformations and deformities, were the third most fre-
quent exclusion criterion identified. CRS is often associ-
ated with myelomeningocele. Even without myelomenin-
gocele, CRS is per se often associated with devastating 
handicaps [15]. Comparing CRS patients with and with-
out myelomeningocele, Balioğlu et al. [15] found that both 
groups were comparable in terms of ambulatory status, 
lower extremity deformities, and impairment of the geni-
tourinary system. Therefore, a benefit of prenatal SBR for 
leg and lower urinary function cannot be expected. Hence, 
it is crucial that CRS is identified conclusively and timely.
Interestingly, patients qualifying for prenatal repair 
rarely opted for postnatal repair (4 patients in this study). 
It seems that patients counseled at our center do not re-
ally consider deciding between the three options prenatal 
repair, postnatal repair, and termination of pregnancy, 
but rather between having the “best possible” child or not 
having the child at all.
Two women decided for an endoscopic procedure 
even though this approach has not yet been proven to 
yield at least equivalent or, ideally, better results than 
open fetal surgery [16].
Given the high prevalence of exclusion criteria and the 
relatively large number of qualifying patients deciding to 
terminate pregnancy (Fig. 1), there is a preselection pro-
cess before on-site evaluation and counseling. First, pre-
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liminary information given by the referring physician 
and/or the patient is recorded on a checklist. Second, 
there is an expert interview over the phone with the pa-
tient. This procedure has led to almost one-third of all 
patients not coming “unnecessarily” to Zurich. Obvious-
ly, this kind of management spares resources for everyone 
involved. However and categorically, correct diagnostic 
workup comes first. Thus, in case of doubt, patients must 
come to our center to avoid exclusion based on wrong 
data or incorrect findings. For our future preselection 
practice, we are considering to use video calls instead of 
or in addition to e-mail and conventional phone calls.
Obviously, this study only reports a single-center ex-
perience. Thus, we cannot generalize our findings or 
translate them to other centers. On the other hand, there 
is only scarce detailed information from other centers, 
since these typically report on operated and not on ex-
cluded patients. Still, this analysis casts quite a compre-
hensive light on the overall recruiting activity of our cen-
ter. It mirrors the entirety of our findings after evaluating 
patients and also the pattern of decisions made by our 
team and the mothers/couples.
Conclusions
It appears that this is the first study which looked in 
detail at why fetal surgery is not performed. Here, a ma-
jority of 65% of potential candidates for fetal SBR were 
not operated. In 52% of this subgroup, one or more exclu-
sion criteria were met (mainly delayed presentation, ab-
sence of hindbrain herniation, and concomitant spinal 
anomalies). This high percentage underscores the neces-
sity of a standard state of the art expert evaluation of every 
single patient at the referral center. The remaining 48% of 
patients were eligible for fetal SBR, but chose another op-
tion (termination of pregnancy, postnatal repair, repair at 
another institution). Finally, fetal surgery was performed 
in only 35% of all patients.
Apart from a detailed understanding of the processes 
taking place before a final decision is made, we identify a 
need for more efficient information pathways regarding 
fetal surgery so that a higher proportion of women carry-
ing a fetus with open SB have a chance to be correctly 
evaluated and counseled. This, in turn, will allow for a 
timely informed final decision making.
Statement of Ethics
The study was approved by the local ethics committee on hu-
man research (KEK-ZH No. 2015-0172, PB_2016-00677).
Disclosure Statement
The authors declare no conflicts of interest.
References
 1 Adzick NS, Thom EA, Spong CY, Brock JW 
3rd, Burrows PK, Johnson MP, et al: A ran-
domized trial of prenatal versus postnatal re-
pair of myelomeningocele. N Engl J Med 
2011; 364: 993–1004.
 2 McLone DG, Dias MS: The Chiari II malfor-
mation: cause and impact. Childs Nerv Syst 
2003; 19: 540–550.
 3 Mitchell LE, Adzick NS, Melchionne J, 
Pasquariello PS, Sutton LN, Whitehead AS: 
Spina bifida. Lancet 2004; 364: 1885–1895.
 4 Just M, Schwarz M, Ludwig B, Ermert J, The-
len M: Cerebral and spinal MR-findings in pa-
tients with postrepair myelomeningocele. Pe-
diatr Radiol 1990; 20: 262–266.
 5 Danzer E, Thomas NH, Thomas A, Friedman 
KB, Gerdes M, Koh J, et al: Long-term neuro-
functional outcome, executive functioning, 
and behavioral adaptive skills following fetal 
myelomeningocele surgery. Am J Obstet Gy-
necol 2016; 214: 269.e1–e8.
 6 Brock JW 3rd, Carr MC, Adzick NS, Burrows 
PK, Thomas JC, Thom EA, et al: Bladder 
function after fetal surgery for myelomenin-
gocele. Pediatrics 2015; 136:e906–e913.
 7 Horst M, Mazzone L, Schraner T, Bodmer C, 
Möhrlen U, Meuli M, et al: Prenatal myelo-
meningocele repair: do bladders better? 
Neurourol Urodyn 2017; 36: 1651–1658.
 8 Carr MC: Urological results after fetal myelo-
meningocele repair in pre-MOMS trial pa-
tients at the Children’s Hospital of Philadel-
phia. Fetal Diagn Ther 2015; 37: 211–218.
 9 Wilson RD, Lemerand K, Johnson MP, Flake 
AW, Bebbington M, Hedrick HL, et al: Repro-
ductive outcomes in subsequent pregnancies 
after a pregnancy complicated by open mater-
nal-fetal surgery (1996–2007). Am J Obstet 
Gynecol 2010; 203: 209.e1–e6.
10 Cohen AR, Couto J, Cummings JJ, Johnson A, 
Joseph G, Kaufman BA, et al: Position state-
ment on fetal myelomeningocele repair. Am J 
Obstet Gynecol 2014; 210: 107–111.
11 Moldenhauer JS, Soni S, Rintoul NE, Spinner 
SS, Khalek N, Martinez-Poyer J, et al: Fetal 
myelomeningocele repair: the post-MOMS 
experience at the Children’s Hospital of Phil-
adelphia. Fetal Diagn Ther 2015; 37: 235–240.
12 Moise KJ Jr, Moldenhauer JS, Bennett KA, 
Goodnight W, Luks FI, Emery SP, et al: Cur-
rent selection criteria and perioperative ther-
apy used for fetal myelomeningocele surgery. 
Obstet Gynecol 2016; 127: 593–597.
13 Egloff A, Bulas D: Magnetic resonance im-
aging evaluation of fetal neural tube defects. 
Semin Ultrasound CT MR 2015; 36: 487–500.
14 Righini A, Parazzini C, Doneda C, Arrigoni F, 
Rustico M, Re TJ, et al: Fetal MRI features re-
lated to the Chiari malformations. Neurol Sci 
2011; 32(suppl 3):S279–S281.
15 Balioğlu MB, Akman YE, Ucpunar H, Al-
bayrak A, Kargın D, Atıcı Y, Büyük AF: Sacral 
agenesis: evaluation of accompanying pathol-
ogies in 38 cases, with analysis of long-term 
outcomes. Childs Nerv Syst 2016; 32: 1693–
1702.
16 Mazzone L, Meuli M: Re: Fetoscopic repair of 
spina bifida: safer and better? Ultrasound Ob-
stet Gynecol 2016; 48: 802.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
E-
M
ed
ie
n 
   
   
   
   
   
   
   
   
 
14
4.
20
0.
17
.3
8 
- 1
/3
/2
01
9 
1:
42
:0
5 
PM
